UNLIMITED TURBO BEAR - IPSEN | Real-time Euronext Paris 06:04:13 2024-06-13 EDT | ||
| 0.825 EUR | +13.79% |
|
| Current month | -29.95% | ||
| 1 month | -36.12% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.825 | +13.79% |
| 24-06-12 | 0.725 | -26.40% |
| 24-06-11 | 0.985 | +10.06% |
| 24-06-10 | 0.895 | +2.29% |
| 24-06-07 | 0.875 | -2.78% |
Real-time Euronext Paris
Last update June 13, 2024 at 06:04 am
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 74U2S | |
| ISIN | DE000SQ1HLY9 |
| Date issued | 2022-10-05 |
| Strike | 140.7 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 2.41 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.685 € |
|---|---|
| Lowest since issue | 0.605 € |
| Spread | 0.01 € |
| Spread % | 1.20% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
125.8
EUR
Average target price
127.3
EUR
Spread / Average Target
+1.17%
- Stock Market
- Certificates
- 74U2S Certificat
